MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 881-890 Newer>
CIO
October 15, 2003
Lafe Low
Project Triage Rapid growth forced the Visiting Nurse Service of New York to develop a customized value methodology that has helped bring projects and goals into focus. mark for My Articles 1 similar article
IndustryWeek
November 1, 2003
Patricia Panchak
Lean Health Care? It Works! A medical researcher has real-life proof that a TPS (Toyota Production System) approach to health care slashes costs for all involved, and a group of Iowa manufacturers is making it happen. mark for My Articles 260 similar articles
BusinessWeek
October 20, 2003
William C. Symonds
Get Used To The Pain Another round of double-digit hikes in health-care costs is in the mail. mark for My Articles 508 similar articles
BusinessWeek
October 20, 2003
Carol Marie Cropper
The New Pinch In Health Coverage Plans are costing more -- again. Here's how to sort them out. mark for My Articles 281 similar articles
Bio-IT World
October 10, 2003
Kevin Davies
Iressa's Trials and Tribulations The Iressa experience highlights the enormous stakes surrounding breakthrough therapies. mark for My Articles 439 similar articles
Bio-IT World
October 10, 2003
Robert M. Frederickson
Capturing Clinical Information Ardais is building a repository of clinical samples and related patient data. mark for My Articles 106 similar articles
Bio-IT World
October 10, 2003
Donna Mendrick
Microarrays That Make Drugs Safe Using DNA chips to discover potential toxicity in new drug compounds -- a key application of toxicogenomics -- can predict adverse effects before they occur, enabling safer clinical trials. mark for My Articles 226 similar articles
BusinessWeek
October 20, 2003
Gene G. Marcial
How Immune Response Targets AIDS Immune Response's Remune is aimed at slowing the advance of HIV and delaying the need for antiretroviral drugs, which have toxic effects. A look at the company's situation and its stock. mark for My Articles 181 similar articles
Knowledge@Wharton
October 8, 2003
Biosciences: High Risk, High Reward, and the Potential for "Real Chaos" While bioscience researchers struggle to understand the workings of the human body, biotech managers and investors are searching for ways to better understand this complex and quickly evolving industry, according to Wharton faculty and lecturers. mark for My Articles 105 similar articles
Managed Care
September 2003
MargaretAnn Cross
Consumer-Directed Health Care: Too Good To Be True? People talk about it as the sure way to control costs and give consumers the choice they seem to want. Are we being realistic? mark for My Articles 176 similar articles
<Older 881-890 Newer>    Return to current articles.